Rallybio Corporaton (RLYB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.6700 -0.0300 (-4.29%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.6700 unch (unch) 16:00 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -57,775 | -74,564 | -66,654 | -47,013 | -26,447 |
Depreciation Amortization | -1,481 | -2,939 | -268 | 109 | 62 |
Accounts payable and accrued liabilities | -698 | -99 | 487 | -976 | 723 |
Other Working Capital | -258 | 4,277 | -936 | -3,779 | 2,120 |
Other Operating Activity | 10,930 | 13,060 | 10,087 | 6,126 | 1,503 |
Operating Cash Flow | $-49,282 | $-60,265 | $-57,284 | $-45,533 | $-22,039 |
Cash Flows From Investing Activities | |||||
PPE Investments | N/A | -12 | -54 | -333 | -137 |
Purchase Of Investment | -50,933 | -110,664 | -201,616 | -2,000 | -1,935 |
Sale Of Investment | 84,425 | 138,334 | 89,500 | N/A | N/A |
Investing Cash Flow | $33,492 | $27,658 | $-112,170 | $-2,333 | $-2,072 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 5,467 | 282 | 51,771 | 86,200 | 145,205 |
Other Financing Activity | -268 | -139 | -693 | -3,233 | -319 |
Financing Cash Flow | $5,199 | $143 | $51,078 | $82,967 | $144,886 |
Beginning Cash Position | 24,494 | 56,958 | 175,334 | 140,233 | 19,458 |
End Cash Position | 13,903 | 24,494 | 56,958 | 175,334 | 140,233 |
Net Cash Flow | $-10,591 | $-32,464 | $-118,376 | $35,101 | $120,775 |
Free Cash Flow | |||||
Operating Cash Flow | -49,282 | -60,265 | -57,284 | -45,533 | -22,039 |
Capital Expenditure | N/A | -12 | -54 | -333 | -137 |
Free Cash Flow | -49,282 | -60,277 | -57,338 | -45,866 | -22,176 |